Cargando…

Diabetic neuropathy research: from mouse models to targets for treatment

Diabetic neuropathy is one of the most serious complications of diabetes, and its increase shows no sign of stopping. Furthermore, current clinical treatments do not yet approach the best effectiveness. Thus, the development of better strategies for treating diabetic neuropathy is an urgent matter....

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Vuong M., Matsumura, Shinji, Katano, Tayo, Funatsu, Nobuo, Ito, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676867/
https://www.ncbi.nlm.nih.gov/pubmed/31290436
http://dx.doi.org/10.4103/1673-5374.259603
_version_ 1783440846920613888
author Pham, Vuong M.
Matsumura, Shinji
Katano, Tayo
Funatsu, Nobuo
Ito, Seiji
author_facet Pham, Vuong M.
Matsumura, Shinji
Katano, Tayo
Funatsu, Nobuo
Ito, Seiji
author_sort Pham, Vuong M.
collection PubMed
description Diabetic neuropathy is one of the most serious complications of diabetes, and its increase shows no sign of stopping. Furthermore, current clinical treatments do not yet approach the best effectiveness. Thus, the development of better strategies for treating diabetic neuropathy is an urgent matter. In this review, we first discuss the advantages and disadvantages of some major mouse models of diabetic neuropathy and then address the targets for mechanism-based treatment that have been studied. We also introduce our studies on each part. Using stem cells as a source of neurotrophic factors to target extrinsic factors of diabetic neuropathy, we found that they present a promising treatment.
format Online
Article
Text
id pubmed-6676867
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66768672019-11-01 Diabetic neuropathy research: from mouse models to targets for treatment Pham, Vuong M. Matsumura, Shinji Katano, Tayo Funatsu, Nobuo Ito, Seiji Neural Regen Res Review Diabetic neuropathy is one of the most serious complications of diabetes, and its increase shows no sign of stopping. Furthermore, current clinical treatments do not yet approach the best effectiveness. Thus, the development of better strategies for treating diabetic neuropathy is an urgent matter. In this review, we first discuss the advantages and disadvantages of some major mouse models of diabetic neuropathy and then address the targets for mechanism-based treatment that have been studied. We also introduce our studies on each part. Using stem cells as a source of neurotrophic factors to target extrinsic factors of diabetic neuropathy, we found that they present a promising treatment. Wolters Kluwer - Medknow 2019-11 /pmc/articles/PMC6676867/ /pubmed/31290436 http://dx.doi.org/10.4103/1673-5374.259603 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review
Pham, Vuong M.
Matsumura, Shinji
Katano, Tayo
Funatsu, Nobuo
Ito, Seiji
Diabetic neuropathy research: from mouse models to targets for treatment
title Diabetic neuropathy research: from mouse models to targets for treatment
title_full Diabetic neuropathy research: from mouse models to targets for treatment
title_fullStr Diabetic neuropathy research: from mouse models to targets for treatment
title_full_unstemmed Diabetic neuropathy research: from mouse models to targets for treatment
title_short Diabetic neuropathy research: from mouse models to targets for treatment
title_sort diabetic neuropathy research: from mouse models to targets for treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676867/
https://www.ncbi.nlm.nih.gov/pubmed/31290436
http://dx.doi.org/10.4103/1673-5374.259603
work_keys_str_mv AT phamvuongm diabeticneuropathyresearchfrommousemodelstotargetsfortreatment
AT matsumurashinji diabeticneuropathyresearchfrommousemodelstotargetsfortreatment
AT katanotayo diabeticneuropathyresearchfrommousemodelstotargetsfortreatment
AT funatsunobuo diabeticneuropathyresearchfrommousemodelstotargetsfortreatment
AT itoseiji diabeticneuropathyresearchfrommousemodelstotargetsfortreatment